Chemotherapy resumption in breast cancer patient after COVID-19
Abstract Background While many studies have verified the effect of recent anti-cancer treatment in patients with COVID-19, there are no data on the optimal time for cancer treatment resumption, as well as the safety of chemotherapy in COVID-19 patients. As many cancer patients are recovering from CO...
Saved in:
| Main Authors: | Julian Horiguchi, Ayako Nakashoji, Naoki Kawahara, Akira Matsui, Takayuki Kinoshita |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Japan Surgical Society
2021-07-01
|
| Series: | Surgical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40792-021-01253-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Form Copy and A'-dependencies: Revisiting Resumption
by: Dalina Kallulli, et al.
Published: (2025-07-01) -
Characterizing treatment interruptions in the OPERA cohort and virologic outcomes after resumption with bictegravir/emtricitabine/tenofovir alafenamide
by: Karam Mounzer, et al.
Published: (2025-07-01) -
Epidural abscess formation after chemotherapy for breast cancer: a case report and literature review
by: Youzhi An, et al.
Published: (2025-01-01) -
Legitimacy of Resumption of jurisdiction in conclusion litigation with factitious defendant’s oath, under jurisprudence of Islamic religions and the Written Law of Iran
by: Mohammad Ali Raghebi, et al.
Published: (2023-09-01) -
The <i>That</i>-Trace Effect—A Surface or a Deep Island Phenomenon? Evidence from Resumption and Prolepsis in Igbo
by: Mary Amaechi, et al.
Published: (2024-10-01)